Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Subscribe to see Kardigan’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kardigan is a saas company headquartered in Princeton, United States. It is publicly listed (KARD) with a market capitalisation of $1.2B. Xcout tracks 17 named people at Kardigan, including Brianne Puglisi (Chief Financial Officer). Xcout recorded 189 job postings from Kardigan in the last 90 days, naming tools such as NetSuite, SAP, Databricks.
11 more named people on record for Kardigan, with roles, board committees and tenure — see the full roster →
Xcout recorded 189 job postings from Kardigan in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Kardigan's hiring signals →
6 corporate events on record, with sources — see the full timeline →
Based on 67 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 158 scale-up healthcare companies.
This describes a hiring pattern — how often Kardigan’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
A few of Kardigan's closest competitors — see the full list of competitors and alternatives →
Nephrogen is a preclinical biotechnology company founded in 2022 and headquartered in New York, NY. The company is dedicated to developing curative genomic medicines for patients suffering from serious diseases.
AliveCor, Inc. is a privately held medical device and software company transforming cardiological care using deep learning and mobile ECG technology. It is headquartered in Mountain View, California.
Heart Health Intelligence Inc. provides a digital cardiovascular health management platform that combines connected medical devices, a mobile application, and a clinically guided AI chatbot. The company serves employers, health plans, and individuals by offering tools to track blood pressure, monitor medications, and encourage proactive lifestyle changes for heart disease prevention.
CardioSignal develops groundbreaking solutions for the detection of heart diseases, including a CE-marked class IIb mobile application for cardiac monitoring. Operating from bases in Turku, Finland and Palo Alto, California, its subsidiary CardioSignal Inc. is based in the USA.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.